Header Logo

Connection

Mandisa Singata-Madliki to Antiretroviral Therapy, Highly Active

Back to Details
This is a "connection" page, showing publications Mandisa Singata-Madliki has written about Antiretroviral Therapy, Highly Active.
Mandisa Singata-Madliki
Connection Strength
0,033
Antiretroviral Therapy, Highly Active
  1. Growth in HIV-1-exposed but uninfected infants treated with lopinavir-ritonavir versus lamivudine: a secondary analysis of the ANRS 12174 trial. Lancet HIV. 2019 05; 6(5):e307-e314.
    View in: PubMed
    Score: 0,033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.